Staphylococcus Species Vocabulary Flashcards
Clinical Case Presentation
- Patient Profile: A 74
-year-old male presented with a painful, swollen, red (erythematous) skin lesion on his arm.
- Disease Progression: The lesion developed rapidly over several days and exuded pus, characterized as a purulent wound.
- Infection Source: The patient reported cutting his hand on a Walmart shopping cart but did not clean or address the injury until returning home that evening.
Overview of Staphylococcal Species
- Staphylococcus aureus:
- Main human pathogen.
- Primarily colonizes the mucous membranes of humans.
- Biochemically distinguished as coagulase-positive.
- Staphylococcus epidermidis:
- Generally harmless skin commensal bacteria forming part of normal human flora.
- Carried by approximately 99% of the human population.
- Biochemically classified as coagulase-negative.
- Staphylococcus saprophyticus:
- Colonizes the human urinary tract.
- Biochemically classified as coagulase-negative.
General Characteristics of Staphylococcus

- Environmental Robustness: Extremely hardy organisms with relative heat resistance.
- Morphology: Gram-positive cocci that divide to form characteristic grape-like clusters.
- Metabolism: Facultative anaerobes.
- Enzyme Production: Catalase-positive.
- Osmotic Tolerance: Capable of growing on selective media containing up to 10% sodium chloride (NaCl).
- Thermal Range: Capable of growth across a temperature range of 18∘C to 40∘C.
Staphylococcus aureus Structural Virulence Factors

- Capsule:
- Thick polysaccharide capsule comprising 11 distinct serotypes.
- Inhibits chemotaxis and phagocytosis by host immune cells.
- Inhibits the proliferation of mononuclear cells.
- Slime Layer (Biofilm):
- A loosely bound, water-soluble extracellular matrix composed of monosaccharides, proteins, and small peptides.
- Facilitates bacterial adherence to host tissues and foreign medical bodies (e.g., implants, catheters).
- Peptidoglycan:
- Provides osmotic stability to the bacterial cell wall.
- Stimulates endogenous pyrogen production, exhibiting endotoxin-like activity.
- Acts as a leukocyte chemoattractant, promoting abscess formation.
- Inhibits phagocytic clearance.
- Teichoic Acid:
- Species-specific major cell wall constituent bound covalently to N
-acetylmuramic acid (NAM) residues or membrane lipids (lipoteichoic acid).
- Binds specifically to fibronectin.
- Poorly immunogenic on its own, but elicits a specific antibody response when complexed with peptidoglycan.
- Protein A:
- Major cell wall surface protein whose expression is tightly regulated.
- Binds the Fc receptor region of immunoglobulins (IgG1, IgG2, and IgG4) at complement-binding sites.
- Inhibits antibody-mediated clearance and classical complement cascade activation.
- Prevents opsonization via C3b.
- Forms circulating immune complexes, acts as a leukocyte chemoattractant, and displays anticomplementary activity.
- Penicillin-Binding Protein 2a (PBP2a):
- A novel penicillin-binding protein conferring resistance to methicillin, oxacillin, and related β
-lactams and cephalosporins.
Toxins Produced by Staphylococcus aureus

- Cytotoxins:
- Exogenous toxins damaging a broad array of cell types, including erythrocytes, fibroblasts, leukocytes, macrophages, and platelets.
- Alpha Toxin: Disrupts vascular smooth muscle; causes rapid efflux of potassium (K+) and influx of sodium (Na+) and calcium (Ca2+), inducing osmotic swelling and cell lysis.
- Beta Toxin: Sphingomyelinase C that hydrolyzes plasma membrane phospholipids, leading to cell destruction.
- Delta Toxin: Acts as a membrane-disrupting detergent targetted against erythrocytes.
- Gamma Toxin: A pore-forming toxin capable of lysing host cells.
- Panton-Valentine (P-V) Leucocidin: A specialized pore-forming cytotoxin targeting leukocytes.
- Exfoliative Toxins (ETA and ETB):
- Serine proteases that specifically cleave intercellular desmosomal bridges within the stratum granulosum layer of the epidermis.
- Do not induce cytolysis or inflammatory cell recruitment.
- Diagnostic Significance: Histological examination reveals neither staphylococcal bacterial cells nor leukocytes in the involved epidermal layer.
- Stimulate protective neutralizing antibody development in host organisms.
- Enterotoxins:
- Act as potent superantigens that nonspecifically activate host T cells, triggering massive systemic cytokine release.
- Stimulate mast cell release of inflammatory mediators, increasing intestinal motility/peristalsis and fluid loss, yielding severe nausea and vomiting.
- Enterotoxin A: The primary toxin associated with staphylococcal food poisoning; highly heat-stable (resists 100∘C for 30 min) and resistant to gastric and jejunal digestive enzymes.
- Enterotoxin B: Responsible for staphylococcal pseudomembranous enterocolitis.
- Toxic Shock Syndrome Toxin-1 (TSST-1):
- A heat- and proteolysis-resistant superantigen mediated by chromosomal insertion.
- Produced by 90% of S. aureus strains isolated from menstruation-associated Toxic Shock Syndrome (TSS).
- Requires a neutral pH and elevated oxygen concentrations for expression.
- Induces non-specific activation of T cells and massive cytokine release, leading to endothelial cell leakage or destruction.
Enzymes Produced by Staphylococcus aureus

- Coagulase:
- Bound Coagulase (Clumping Factor): Directly converts soluble fibrinogen into insoluble fibrin, causing bacterial agglutination and clumping.
- Free Coagulase: Reacts with coagulase-reacting factor (CRF) to form a staphylothrombin complex, which enzymatically catalyzes fibrinogen conversion into insoluble fibrin.
- Pathogenic Role: Forms a protective fibrin barrier surrounding staphylococci (particularly in abscess formation) to shield bacteria from phagocytic engulfment; contributes directly to localized coagulation and thrombosis.
- Hyaluronidase: Hydrolyzes hyaluronic acid present in the acellular matrix of connective tissues, facilitating tissue invasion.
- Fibrinolysin (Staphylokinase): Dissolves host fibrin clots, promoting bacterial systemic dispersion.
- Lipases: Hydrolyze host lipids, ensuring bacterial survival and colonization in sebaceous cutaneous sites.
- Nuclease: Hydrolyzes viscous extracellular host DNA.
Epidemiology and At-Risk Populations

- Epidemiological Profile:
- Ubiquitous organism present as normal flora on human skin, particularly in warm, moist skin folds and the anterior nares.
- Susceptible to elevated temperatures, chemical disinfectants, and topical antiseptics.
- Capable of long-term survival on dry inanimate surfaces.
- Transmitted via direct person-to-person contact or indirect contact via fomites; effectively prevented by proper hand hygiene.
- High-Risk Patient Populations:
- Neonates/Infants: High risk for Staphylococcal Scalded Skin Syndrome (SSSS).
- Young Children: High incidence of cutaneous infections due to poor hand hygiene.
- Menstruating Females: High susceptibility to Toxic Shock Syndrome (TSS).
- Patients with Intravascular Catheters: Susceptible to systemic bacteremia and acute endocarditis.
- Patients with Cerebrospinal Shunts: At risk for staphylococcal meningitis.
- Patients with Pulmonary Compromise or Viral Respiratory Infections: Increased risk for secondary pneumonia.
- Key Clinical Risk Factors:
- Presence of indwelling foreign material/medical devices.
- Recent surgical procedures.
- Disruption of indigenous microflora caused by broad-spectrum antibiotic administration.
Clinical Pathologies Associated with Staphylococcus aureus
- Staphylococcal Scalded Skin Syndrome (SSSS / Ritter Disease):
- Abrupt onset of localized perioral erythema and inflammation that spreads across the entire body within approximately 2
days.
- Demonstrates Nikolsky sign: gentle mechanical pressure induces epidermal displacement.
- Large cutaneous bullae form, followed by widespread desquamation of epithelial layers.
- Blister fluid is clear and devoid of staphylococcal organisms or white blood cells.
- Spontaneously resolves within 7–10 days without cutaneous scarring.
- Primarily affects neonates and infants; exceptionally rare in adults or older children.

- Bullous Impetigo:
- A localized form of SSSS characterized by superficial skin bullae.
- Unlike classic SSSS, blister fluid contains viable bacterial organisms.
- Epithelial sloughing does not occur beyond the localized lesion.
- Highly communicable condition observed in infants and adults.

- Staphylococcal Food Poisoning:
- Intoxication caused by ingesting preformed heat-stable Enterotoxin A.
- Common vehicle foods include processed meats, custard-filled pastries, potato salad, and ice cream contaminated by human food handlers.
- Features an abrupt onset of violent vomiting occurring 4–6 hours post-ingestion.
- Symptom duration is brief, typically resolving within 24 hours.
- Associated symptoms include low-grade fever, watery diarrhea, abdominal cramps, and dehydration.
- Cutaneous Infections:
- Impetigo: Superficial pyogenic infection affecting young children.
- Folliculitis: Pyogenic infection confined to hair follicles.
- Furuncles (Boils): Extension of folliculitis into deeper tissues.
- Carbuncles: Coalescence of multiple furuncles extending into deep subcutaneous tissues.
- Wound Infections: Inoculation of skin flora into surgical incisions or traumatic wounds.
- Bacteremia:
- Invasion of bacteria into the bloodstream; greater than 50% of cases are nosocomial (acquired via contaminated IV catheters or surgical site contamination).
- Persistent bacteremia leads to metastatic dissemination causing endocarditis, pneumonia, osteomyelitis, and septic arthritis.
- Endocarditis:
- Acute, life-threatening infection of cardiac valves carrying a mortality rate of approximately 50%
.
- Presents initially with non-specific flu-like symptoms followed by rapid clinical deterioration.
- Requires urgent medical and surgical intervention.
- Features peripheral embolization caused by septic thrombi detachment.
- Pneumonia and Empyema:
- Aspiration Pneumonia: Manifests in young children, elderly patients, or individuals with underlying cystic fibrosis, influenza, or COPD.
- Hematogenous Pneumonia: Results from hematogenous seeding in patients with bacteremia or endocarditis.
- Necrotizing Pneumonia: Severe form typically caused by methicillin-resistant S. aureus (MRSA); features massive hemoptysis, septic shock, and exceptionally high mortality.
- Osteomyelitis and Septic Arthritis:
- Bone tissue abscesses resulting from hematogenous dissemination or secondary trauma/contiguous focus of infection.
- Presents with intense localized bone pain and fever.
- Affects long bones in children; manifests as vertebral osteomyelitis in adults (causing severe localized back pain).
- Surgical drainage and antibiotic therapy yield high cure rates.
Coagulase-Negative Staphylococci (CoNS)
- Staphylococcus epidermidis:
- Predominant skin commensal and opportunistic pathogen.
- High predilections for colonizing indwelling vascular catheters, artificial joint prostheses, and prosthetic heart valves via slime layer production.
- Microscopically identical to S. aureus; differentiated using negative coagulase enzymatic assays.
- Staphylococcus saprophyticus:
- Coagulase-negative species that selectively colonizes the female urinary tract.
- Major cause of community-acquired urinary tract infections (UTIs) in young, sexually active females.
- Clinical symptoms include dysuria, pyuria, and abundant bacteriuria.
- Reinfection following appropriate antimicrobial treatment is rare.
Diagnostic Methods and Species Differentiation

- Microscopy: Gram-positive cocci arranged in grape-like clusters.
- Polymerase Chain Reaction (PCR): Used for molecular identification and screening for methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA) nasal colonization.
- Culture Characteristics:
- Sheep Blood Agar: Inoculation yields large, smooth, golden-yellow colonies within 24 hours displaying clear β
-hemolysis surrounding colonies.
- Mannitol Salt Agar (MSA): Selective media containing high salt (10%NaCl). S. aureus ferments mannitol, lowering pH and turning agar yellow. Other staphylococcal species grow but do not ferment mannitol.
- Coagulase Assay: Differentiates coagulase-positive S. aureus from coagulase-negative species (S. epidermidis, S. saprophyticus).
- Mass Spectrometry (MALDI-TOF): Rapid, precise automated species identification.
Treatment Strategies
- Antimicrobial Susceptibility Testing: Mandatory prior to definitive therapy due to widespread plasmid- and chromosome-mediated resistance against β
-lactam antibiotics.
- Oral Therapeutic Options:
- Trimethoprim-sulfamethoxazole (TMP/SMX)
- Tetracyclines (e.g., Doxycycline)
- Clindamycin
- Linezolid
- Intravenous (IV) Therapeutic Options:
- Vancomycin
- Daptomycin
- Tigecycline
- Linezolid